Cazanave C - Search Results

1

Is the subcutaneous route an alternative for administering ertapenem to older patients? PHACINERTA study.

Roubaud Baudron C, Legeron R, Ollivier J, Bonnet F, Greib C, Guerville F, Cazanave C, Kobeh D, Cressot V, Moneger N, Videau MN, Thiel E, Foucaud C, Lafargue A, de Thezy A, Durrieu J, Bourdel Marchasson I, Pinganaud G, Breilh D. Roubaud Baudron C, et al. Among authors: cazanave c. J Antimicrob Chemother. 2019 Dec 1;74(12):3546-3554. doi: 10.1093/jac/dkz385. J Antimicrob Chemother. 2019. PMID: 31730164 Clinical Trial.

2

[Autoimmune hepatitis in a HIV-HCV co-infected patient: diagnostic ant therapeutic difficulties].

Cazanave C, Rakotondravelo S, Morlat P, Blanco P, Bonnet F, Beylot J. Cazanave C, et al. Rev Med Interne. 2006 May;27(5):414-9. doi: 10.1016/j.revmed.2006.01.016. Epub 2006 Mar 3. Rev Med Interne. 2006. PMID: 16545501 French.

3

Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort.

Wittkop L, Breilh D, Da Silva D, Duffau P, Mercié P, Raymond I, Anies G, Fleury H, Saux MC, Dabis F, Fagard C, Thiébaut R, Masquelier B, Pellegrin I; ANRS CO3 Aquitaine Cohort. Wittkop L, et al. J Antimicrob Chemother. 2009 Jun;63(6):1251-5. doi: 10.1093/jac/dkp114. Epub 2009 Mar 31. J Antimicrob Chemother. 2009. PMID: 19336453 Free PMC article. Clinical Trial.

4

Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007.

Bénard A, Mercié P, Alioum A, Bonnet F, Lazaro E, Dupon M, Neau D, Dabis F, Chêne G; Groupe d'Epidémiologie Clinique du Sida en Aquitaine. Bénard A, et al. PLoS One. 2010 Jan 26;5(1):e8896. doi: 10.1371/journal.pone.0008896. PLoS One. 2010. PMID: 20126646 Free PMC article.

5

Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy.

Dauchy FA, Lawson-Ayayi S, de La Faille R, Bonnet F, Rigothier C, Mehsen N, Miremont-Salamé G, Cazanave C, Greib C, Dabis F, Dupon M. Dauchy FA, et al. Among authors: cazanave c. Kidney Int. 2011 Aug;80(3):302-9. doi: 10.1038/ki.2011.124. Epub 2011 May 4. Kidney Int. 2011. PMID: 21544066 Free article.

6

Cognitive disorders in HIV-infected patients: are they HIV-related?

Bonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy FA, Mercié P, Greib C, Richert L, Neau D, Catheline G, Dehail P, Dabis F, Morlat P, Dartigues JF, Chêne G; S CO3 Aquitaine Cohort. Bonnet F, et al. AIDS. 2013 Jan 28;27(3):391-400. doi: 10.1097/QAD.0b013e32835b1019. AIDS. 2013. PMID: 23079813

7

Severe morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine Cohort.

Hessamfar M, Colin C, Bruyand M, Decoin M, Bonnet F, Mercié P, Neau D, Cazanave C, Pellegrin JL, Dabis F, Morlat P, Chêne G; GECSA study group. Hessamfar M, et al. Among authors: cazanave c. PLoS One. 2014 Jul 30;9(7):e102671. doi: 10.1371/journal.pone.0102671. eCollection 2014. PLoS One. 2014. PMID: 25076050 Free PMC article.

8

Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).

Vandenhende MA, Perrier A, Bonnet F, Lazaro E, Cazanave C, Reigadas S, Chêne G, Morlat P; AIDS Clinical Epidemiology Group of Aquitaine. Vandenhende MA, et al. Among authors: cazanave c. Antivir Ther. 2015;20(6):655-60. doi: 10.3851/IMP2949. Epub 2015 Mar 4. Antivir Ther. 2015. PMID: 25735799

9

Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000-2012.

Collin A, Le Marec F, Vandenhende MA, Lazaro E, Duffau P, Cazanave C, Gérard Y, Dabis F, Bruyand M, Bonnet F; ANRS CO3 Aquitaine Cohort Study Group. Collin A, et al. Among authors: cazanave c. PLoS One. 2016 Apr 6;11(4):e0152970. doi: 10.1371/journal.pone.0152970. eCollection 2016. PLoS One. 2016. PMID: 27050752 Free PMC article.

10

Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults.

Duffau P, Ozanne A, Bonnet F, Lazaro E, Cazanave C, Blanco P, Rivière E, Desclaux A, Hyernard C, Gensous N, Pellegrin I, Wittkop L. Duffau P, et al. Among authors: cazanave c. AIDS. 2018 Jul 31;32(12):1651-1660. doi: 10.1097/QAD.0000000000001875. AIDS. 2018. PMID: 29762168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page